Peer-reviewed article
Are “Stranger Donors” Irrational?
This chapter seeks to understand the motivations of people who offered to donate a kidney to a stranger. It explores the degree of emotional relationship that was essential to justify the claim that donation provided a psychological…
This chapter seeks to understand the motivations of people who offered to donate a kidney to a stranger. It explores the degree of emotional relationship that was essential to justify the claim that donation provided a psychological benefit to the donor. The chapter also mentions a law in the United Kingdom called the Unrelated Live Transplant Registry Authority which required organ donors to provide proof that they had a relationship with the recipient. In the United States, however, there is no federal legislation or public policy regulating stranger donors. The chapter then turns to discuss a study led by nephrologist Aaron Spital showing how attitudes within the transplant community gradually shifted from almost universal rejection of stranger donors to their gradual acceptance. It assesses the struggles that nephrologists went through in trying to determine whether such altruists were noble or irrational. Ultimately, the chapter offers a unique glimpse into the motivations of an altruistic donor and into the forms of skepticism that doctors and psychologists bring to evaluations of such donors.
Related writing.
Why the Dutch Keep Pediatric Euthanasia Illegal
Pediatric euthanasia in The Netherlands has a unique legal status - it is illegal, openly practiced, and well-regulated. The most surprising part isn't the law that enabled this — it's what happened after.
Associations of Physician Perspectives, Personal Choices, and Counseling for Severe Congenital Heart Defects
OBJECTIVE: To assess whether physicians' perspectives of outcomes or personal choices are associated with prenatal counseling for termination of pregnancy (TOP) or perinatal hospice for severe congenital heart defects (CHDs). METHOD:…
Variation in the extent to which patient information leaflets describe potential benefits and harms of trial interventions: a commentary
Clinical trial participants must understand the possible risks and benefits of trial interventions before providing their informed consent to participate. The aim of this commentary is twofold: to summarize the discrepancies in the extent…
Pediatric Gender Medicine—Reply
Third, emerging evidence suggests that modulating glycosylation pathways could offer a novel therapeutic strategy for asthma management.Xie et al 5 proposed that targeting glycan recognition receptors, such as sialic acid-binding…
About the author
John D. Lantos is a pediatrician and bioethicist writing on AI in medicine, neonatal intensive care, and end-of-life decisions. His essays appear in JAMA, JAMA Pediatrics, the Hastings Center Report, the New England Journal of Medicine, and Aeon. Read more about John.